Related Experiment Videos
[Clinical criteria in evaluating recovery from depression. Methodologic aspects]
1Unité de Psychiatrie, C.H.U. du Sart Tilman, Liège, Belgique.
L'Encephale
|August 1, 1993
Summary
Major depression affects 16-20% of Europeans, but its natural course is poorly understood. Standardized definitions are crucial for evaluating antidepressant effectiveness in acute, maintenance, and prophylactic treatments.
Area of Science:
- Psychiatry
- Epidemiology
- Clinical Research
Context:
- Major depression has a high lifetime prevalence in Europe (16-20%).
- Understanding the natural course of depressive illness is limited.
- Longitudinal studies are hindered by inconsistent terminology for illness phases.
Purpose:
- To highlight the need for validated, internationally accepted definitions for depression course markers.
- To emphasize the necessity of these definitions for assessing antidepressant efficacy at different treatment levels.
Summary:
- Current understanding of major depression's natural course is limited by inconsistent definitions of remission, recovery, relapse, and recurrence.
- Proposed definitions require clinical validation to standardize research and clinical practice.
- Standardized definitions are essential for evaluating antidepressants in acute, maintenance, and prophylactic treatment.
Impact:
- Facilitate consistent assessment of antidepressant efficacy.
- Improve the design and interpretation of longitudinal studies on depression.
- Advance clinical validation of proposed depression course definitions.